Finance

Lists
059210:KOSDAQ
Metabiomed Co Ltd
â‚©3,900.00
+1.69%
(+65.00) 1D
Sep 8, 3:30:17 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 059210...
Open
â‚©3,835
High
â‚©3,935
Low
â‚©3,785
Mkt. cap
105.97B
Avg. vol.
86.21K
Volume
114.15K
Dividend
2.76%
Quarterly dividend
â‚©27
Ex-dividend date
Dec 27, 2024
P/E ratio
6.50
52-wk high
â‚©6,600
52-wk low
â‚©3,265
EPS
â‚©600
Shares outstanding
27.17M
No. of employees
314
Open
â‚©3,835
High
â‚©3,935
Low
â‚©3,785
Mkt. cap
105.97B
Avg. vol.
86.21K
Volume
114.15K
Dividend
2.76%
Quarterly dividend
â‚©27
Ex-dividend date
Dec 27, 2024
P/E ratio
6.50
52-wk high
â‚©6,600
52-wk low
â‚©3,265
EPS
â‚©600
Shares outstanding
27.17M
No. of employees
314
About Metabiomed Co Ltd
CEO-
Employees314
Founded1990
Headquarters-
SectorMedical device
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
23.53B
26.24B
24.42B
26.99B
Cost of goods sold
10.92B
14.09B
11.46B
11.55B
Cost of revenue
10.92B
14.09B
11.46B
11.55B
Research and development expenses
1.34B
1.77B
1.26B
1.33B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.08B
7.42B
6.48B
7.51B
Operating expense
7.54B
9.45B
8.11B
9.17B
Total operating expenses
18.45B
23.54B
19.57B
20.72B
Operating income
5.08B
2.70B
4.85B
6.28B
Other non operating income
-97.64M
-1.29B
-1.06B
1.13B
EBT including unusual items
5.79B
921.97M
4.69B
9.22B
EBT excluding unusual items
5.28B
1.85B
5.02B
7.65B
Income tax expense
1.33B
-629.63M
299.35M
2.92B
Effective tax rate
23.02%
-68.29%
6.38%
31.66%
Other operating expenses
-
-
-
-
Net income
4.46B
1.67B
4.52B
6.33B
Net profit margin
18.96%
6.38%
18.52%
23.47%
Earnings per share
143.00
-
-
-
Interest and investment income
267.85M
260.77M
207.65M
158.62M
Interest expense
-583.98M
-513.70M
-487.40M
-472.87M
Net interest expenses
-316.13M
-252.93M
-279.75M
-314.25M
Depreciation and amortization charges
309.89M
135.77M
313.61M
356.30M
EBITDA
6.50B
4.20B
6.27B
7.89B
Gain or loss from assets sale
941.46M
-638.84M
-618.30K
-8.06M
AI content may include mistakes. Learn more
Google apps